Abstract
Osteoporosis is a systemic disease characterized by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and propensity to fracture. Environmental factors during early life, including those in utero, may influence bone mass during later life and, consequently, the risk of osteoporosis. Epigenetic mechanisms play central roles in the differentiation of bone cells, osteoblasts and osteoclasts, responsible for bone formation and bone resorption, respectively. A few studies have shown some differentially methylated genes in patients with osteoporosis. They include genes belonging to the Wnt pathway, which is an important regulator of osteoblast differentiation, and other genes involved in the development of the skeleton. Likewise, some miRNAs may be differentially expressed in these patients. However, those preliminary results need to be replicated in other cohorts. Unlike the genome, the epigenome is cell-specific and changes with aging and environmental factors. Therefore, the design and interpretation of epigenetic epidemiology studies pose a number of practical difficulties. A framework for the critical appraisal of these studies is proposed.
Keywords: Critical appraisal, DNA methylation, Epigenetics, microRNA, miRNA, Osteoporosis.
Graphical Abstract
Current Genomics
Title:Epigenetics of Osteoporosis: Critical Analysis of Epigenetic Epidemiology Studies
Volume: 16 Issue: 6
Author(s): José A. Riancho
Affiliation:
Keywords: Critical appraisal, DNA methylation, Epigenetics, microRNA, miRNA, Osteoporosis.
Abstract: Osteoporosis is a systemic disease characterized by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and propensity to fracture. Environmental factors during early life, including those in utero, may influence bone mass during later life and, consequently, the risk of osteoporosis. Epigenetic mechanisms play central roles in the differentiation of bone cells, osteoblasts and osteoclasts, responsible for bone formation and bone resorption, respectively. A few studies have shown some differentially methylated genes in patients with osteoporosis. They include genes belonging to the Wnt pathway, which is an important regulator of osteoblast differentiation, and other genes involved in the development of the skeleton. Likewise, some miRNAs may be differentially expressed in these patients. However, those preliminary results need to be replicated in other cohorts. Unlike the genome, the epigenome is cell-specific and changes with aging and environmental factors. Therefore, the design and interpretation of epigenetic epidemiology studies pose a number of practical difficulties. A framework for the critical appraisal of these studies is proposed.
Export Options
About this article
Cite this article as:
Riancho A. José, Epigenetics of Osteoporosis: Critical Analysis of Epigenetic Epidemiology Studies, Current Genomics 2015; 16 (6) . https://dx.doi.org/10.2174/1389202916666150817213250
DOI https://dx.doi.org/10.2174/1389202916666150817213250 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Genetic Chemoprotection with Mutant O6-Alkylguanine-DNA-Alkyltransferases
Current Gene Therapy Highlighting the Protective or Degenerative Role of AMPK Activators in Dementia Experimental Models
CNS & Neurological Disorders - Drug Targets Pregnancy Complicated by the Most Frequent Forms of Maturity Onset Diabetes of the Young: A Narrative Review on Its Pharmacological Implications
Current Reviews in Clinical and Experimental Pharmacology The CLCA Gene Family: Putative Therapeutic Target for Respiratory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Gist Representations and Communication of Risks about HIV-AIDS: A Fuzzy-Trace Theory Approach
Current HIV Research Recent Progress in Anticonvulsant Drug Research: Strategies for Anticonvulsant Drug Development and Applications of Antiepileptic Drugs for Non-Epileptic Central Nervous System Disorders
Current Topics in Medicinal Chemistry Access to Medicines and the Safety of the People
Reviews on Recent Clinical Trials MEK Inhibition Increases Lapatinib Sensitivity Via Modulation of FOXM1
Current Medicinal Chemistry Multidisciplinary Cancer Therapy with Telomerase-Specific Oncolytic Adenovirus
Current Cancer Therapy Reviews Neuroblastoma and Stem Cell Therapy: An Updated Review
CNS & Neurological Disorders - Drug Targets Seeds of Mung Bean (<i>Vigna radiata</i> (L.) R.Wilczek): Taxonomy, Phytochemistry, Medicinal Uses and Pharmacology
Current Bioactive Compounds Systems Biology Approach for the Identification of Diagnostic and Therapeutic Targets in Medulloblastomas
Current Pharmacogenomics and Personalized Medicine In-Situ Hybridization as a Molecular Tool in Cancer Diagnosis and Treatment
Current Medicinal Chemistry High Throughput Screening Operations at the University of Kansas
Combinatorial Chemistry & High Throughput Screening Future Developments in Osteoporosis Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets Modulators of Voltage-Dependent Calcium Channels for the Treatment of Nervous System Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Chelating Agents for Metal Intoxication
Current Medicinal Chemistry Nitric Oxide: Cancer Target or Anticancer Agent?
Current Cancer Drug Targets Targeting Cancer Stem Cells with Repurposed Drugs to Improve Current Therapies
Recent Patents on Anti-Cancer Drug Discovery ABC Subfamily D Proteins and Very Long Chain Fatty Acid Metabolism as Novel Targets in Adrenoleukodystrophy
Current Drug Targets